Solutions to Viral Diseases
To negate the impacts of bacterial and viral diseases on food security by creating a world without antibiotics combined with unique cutting-edge solutions to bacterial and viral diseases
To drastically reduce humanity’s reliance on antibiotics and to develop a simpler, more sustainable way to combat viral diseases in global livestock production and in crop plants
Multiple Resistance to Antibiotics and the continuous threat posed by Viral diseases
Multiple resistance to antibiotics
Viral Diseases Continuous Threats
Our specialist-designed, antibacterial solutions based on highly specific bacteriophages targeting key bacterial diseases in fauna and flora are combined with antiviral solutions from a cutting-edge implementation of Gene Editing (GE) and gene silencing (RNAi)
A bacteriophage (phage) is a virus that infects bacteria. In fact, the word “bacteriophage” literally means “bacteria eater,” because bacteriophages destroy their host cells. They are the natural enemies (viruses) of bacteria and one of the main regulators of bacterial populations on Earth
Their high efficiency is a result of a combination of viral propagation and millions of years of co-evolution with bacteria. Phages eliminate 50% of the Earth’s bacterial population every 48 hours and are the most abundant and omnipresent micro-organism on Earth.
They leave no ecological footprint as all they are composed of is proteins and DNA-RNA.
The rise of antimicrobial resistant (AMR) bacteria, however, together with consumer calls for antibiotic-free products, pose problems that threaten sustainable agriculture.
Bacteriophages are a viable bacterial disease control alternative to antibiotics.
Co - Founder Agronomy & Regulatory lead
Over 38 years experience in Plant Protection. Brings diverse & multidisciplinary knowledge in agricultural and food related technologies from both corporate and startup perspectives. Past Head of Development at Adama Agricultural Solutions. Scouted for the Fund set up by Bayer CropScience & Trendlines in Israel and is active in two startups in Food & AgTech. Jonathan holds a BSc & MSc from the Hebrew University.
Dr. Sergey Bujanover
CTO PhD Molecular Virology, BA Medicine, MSc Pharmacology
A highly skilled scientist with extensive experience in Microbiology, Molecular Biology, Proteomics, Immunology, Tissue Culture and Biodistribution studies in animals, in addition to unparalleled experience in working with phages